US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Senesco Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Senesco Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Sartorius Stedim Biotech S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Sartorius Stedim Biotech S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Complete Genomics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
RTI Biologics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' RTI Biologics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Rosetta Genomics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Rosetta Genomics, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Advaxis, Inc. (formerly Great Expectations & Associates, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Advaxis, Inc. (formerly Great Expectations & Associates, Inc.) Mergers & Acquisitions (M&A), Partnerships ...  |  read more...
USD 350
Albany Molecular Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Albany Molecular Research, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
United Therapeutics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' United Therapeutics Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Generex Biotechnology Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Generex Biotechnology Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Genmab A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Genmab A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Marina Biotech, Inc. (formerly MDRNA, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Marina Biotech, Inc. (formerly MDRNA, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Global Personalized Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts
6/1/2015 | published by: Current Partnering
... discovery or development stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. ...  |  read more...
USD 3,495
Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2015
6/1/2015 | published by: Current Partnering
... into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter asset purchase deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides ...  |  read more...
USD 2,995
Cloud Market In Healthcare technologies, EHR Market, Digital pathology market, Clinical, EMR, SaaS, Bioinformatics, Digital pathology, Hybrid Market - Global Trends, Challenges, Opportunities & Forecasts 2014 – 2020
5/17/2015 | published by: Occams Business Research & Consultancy
... maintenance and management of a large amount of data stored in a centralized database that can be accessed when needed. It saves a rather significant amount of infrastructural costs. Healthcare industry has lagged behind other ...  |  read more...
USD 4,000
Emerging Diagnostic Imaging Market – Devices (Nuclear Imaging Systems, 3D imaging, Tactile imaging, Tomography, Emerging Diagnostic Biomarkers, Wearable diagnostic devices), Global Industry Analysis, Growth, Trends, Forecast 2014-2020
5/22/2015 | published by: Occams Business Research & Consultancy
... a patient’s physical condition, which is then used to diagnose, monitor or treat medical conditions, thus playing an important role in improving public health of all age groups. X-ray based examinations are crucial in all ...  |  read more...
USD 4,000
North America Food Enzymes Market-Growth, Trends And Forecast (2015-2020)
5/25/2015 | published by: Mordor Intelligence LLP
... the food enzymes market. Food enzymes are a major food additives which convert complex molecules in to simpler ones in our diet. The food enzymes market was valued is expected to reach US$ 2695 million ...  |  read more...
USD 3,850
Spain Food Enzymes Market-Growth, Trends and Forecast (2015-2020)
5/25/2015 | published by: Mordor Intelligence LLP
... food enzymes market. Food enzymes are a major food additives which convert complex molecules in to simpler ones in our diet. The food enzymes market was valued is expected to reach US$ 2695 million by ...  |  read more...
USD 3,250
France Food Enzymes Market-Growth, Trends and Forecast (2015-2020)
5/25/2015 | published by: Mordor Intelligence LLP
... food enzymes market. Food enzymes are a major food additives which convert complex molecules in to simpler ones in our diet. The food enzymes market was valued is expected to reach US$ 2695 million by ...  |  read more...
USD 3,250
Anti-CD19 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD19 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD19 Antibody- ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD274 (PD-L1) Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD28 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD28 Antibody- ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD3 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD3 Antibody- ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD30 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD30 Antibody- ...  |  read more...
USD 1,250
1  2    4    6  7  8  9  10